IVERIC bio logo
IVERIC bio ISEE
report update icon

Quartalsbericht 2023-Q1
hinzugefügt 16.05.2026

IVERIC bio Gesamtes Eigenkapital | ISEE

Gesamtes Eigenkapital Jährlich IVERIC bio

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
535 M 361 M 192 M 117 M 124 M 38 M -94.6 M 59.9 M 129 M 170 M -123 M -102 M -77.3 M -52.8 M -35.1 M -12 M

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
535 M -123 M 76.7 M

Gesamtes Eigenkapital Vierteljährlich IVERIC bio

2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
477 M 535 M 260 M 293 M 333 M 361 M 226 M 140 M 167 M 192 M 215 M 238 M 105 M 117 M 89.5 M 102 M 114 M 124 M 5.43 M 17.5 M 28.1 M 38 M 43.9 M -149 M -132 M -94.6 M -36.6 M 14.5 M 33.2 M 59.9 M 83.1 M 114 M 142 M 129 M 176 M 159 M 207 M 170 M 189 M 170 M 170 M -123 M -123 M - - -102 M - - -

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
535 M -149 M 120 M

Gesamtes Eigenkapital anderer Aktien in der Pharmaeinzelhändler

Name Gesamtes Eigenkapital Preis % 24h Marktkapitalisierung Land
Kaleido Biosciences Kaleido Biosciences
KLDO
10.6 M - -3.69 % $ 12.4 M usaUSA
VBI Vaccines VBI Vaccines
VBIV
7.53 M - -50.87 % $ 1.09 M usaUSA
CTI BioPharma Corp. CTI BioPharma Corp.
CTIC
-17.6 M - - $ 1.2 B usaUSA
Decibel Therapeutics Decibel Therapeutics
DBTX
81.8 M - - $ 123 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
189 M $ 26.35 -3.02 % $ 3.35 B usaUSA
ObsEva SA ObsEva SA
OBSV
8.35 M - -15.52 % $ 10.5 M schweizSchweiz
Arrowhead Pharmaceuticals Arrowhead Pharmaceuticals
ARWR
50.3 M $ 41.53 -4.86 % $ 5.88 B usaUSA
Monopar Therapeutics Monopar Therapeutics
MNPR
138 M $ 69.02 -1.81 % $ 512 M usaUSA
Poseida Therapeutics Poseida Therapeutics
PSTX
104 M - - $ 857 M usaUSA
Y-mAbs Therapeutics Y-mAbs Therapeutics
YMAB
92 M - - $ 382 M usaUSA
Satsuma Pharmaceuticals Satsuma Pharmaceuticals
STSA
46.8 M - -0.9 % $ 36.5 M usaUSA
Anavex Life Sciences Corp. Anavex Life Sciences Corp.
AVXL
94.9 M $ 0.59 -11.3 % $ 50.3 M usaUSA
SpringWorks Therapeutics SpringWorks Therapeutics
SWTX
481 M - - $ 3.48 B usaUSA
Axon Enterprise Axon Enterprise
AXON
3.24 B $ 291.02 -5.2 % $ 22.7 B usaUSA
Infinity Pharmaceuticals Infinity Pharmaceuticals
INFI
-19.1 M - -46.98 % $ 3.57 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
-1.1 M - - $ 7.46 M israelIsrael
Evelo Biosciences Evelo Biosciences
EVLO
-4.99 M - -14.46 % $ 27.9 M usaUSA
Morphic Holding Morphic Holding
MORF
697 M - - $ 2.42 B usaUSA
Genocea Biosciences Genocea Biosciences
GNCA
27.1 M - -15.0 % $ 3.04 M usaUSA
Biogen Biogen
BIIB
18.3 B $ 249.55 0.98 % $ 36.6 B usaUSA
Bristol-Myers Squibb Company Bristol-Myers Squibb Company
BMY
18.5 B $ 58.74 0.69 % $ 119 B usaUSA
Eiger BioPharmaceuticals Eiger BioPharmaceuticals
EIGR
-14.5 M - -9.21 % $ 2.55 M usaUSA
IGM Biosciences IGM Biosciences
IGMS
48.2 M - - $ 76.9 M usaUSA
Merrimack Pharmaceuticals Merrimack Pharmaceuticals
MACK
18.7 M - - $ 216 M usaUSA
Rubius Therapeutics Rubius Therapeutics
RUBY
15.1 M - -33.55 % $ 7.81 M usaUSA
Mirati Therapeutics Mirati Therapeutics
MRTX
997 M - - $ 3.3 B usaUSA
InVivo Therapeutics Holdings Corp. InVivo Therapeutics Holdings Corp.
NVIV
15.7 M - -37.48 % $ 476 K usaUSA
Bellicum Pharmaceuticals Bellicum Pharmaceuticals
BLCM
2.02 M - -9.72 % $ 5.89 M usaUSA
Orchard Therapeutics plc Orchard Therapeutics plc
ORTX
98.3 M - 1.02 % $ 90.8 M britainBritain
La Jolla Pharmaceutical Company La Jolla Pharmaceutical Company
LJPC
-66.7 M - - $ 154 M usaUSA
Oyster Point Pharma Oyster Point Pharma
OYST
99.5 M - - $ 300 M usaUSA
Intercept Pharmaceuticals Intercept Pharmaceuticals
ICPT
93.1 M - - $ 643 M usaUSA
Chinook Therapeutics Chinook Therapeutics
KDNY
442 M - - $ 2.6 B usaUSA
Syros Pharmaceuticals Syros Pharmaceuticals
SYRS
16.7 M - -8.44 % $ 3.4 M usaUSA
NanoViricides NanoViricides
NNVC
8.68 M $ 1.15 -2.54 % $ 23.2 M usaUSA
GT Biopharma GT Biopharma
GTBP
5.79 M $ 2.93 -7.86 % $ 16.2 M usaUSA
Zymeworks Zymeworks
ZYME
249 M $ 26.41 -1.68 % $ 1.36 B canadaCanada
Aldeyra Therapeutics Aldeyra Therapeutics
ALDX
44.3 M $ 0.84 16.41 % $ 50.4 M usaUSA
Citius Pharmaceuticals Citius Pharmaceuticals
CTXR
67.6 M $ 0.51 1.61 % $ 5.64 M usaUSA
Cytokinetics, Incorporated Cytokinetics, Incorporated
CYTK
-660 M $ 50.7 -1.48 % $ 6.09 M usaUSA
DBV Technologies S.A. DBV Technologies S.A.
DBVT
169 M $ 9.03 -4.14 % $ 1.26 B franceFrance
Precision BioSciences Precision BioSciences
DTIL
92.2 M $ 7.37 6.66 % $ 94.5 M usaUSA
Exelixis Exelixis
EXEL
2.16 B $ 64.59 -1.88 % $ 17.5 B usaUSA
Fennec Pharmaceuticals Fennec Pharmaceuticals
FENC
35.5 M $ 13.09 -2.68 % $ 374 M usaUSA
Cardiff Oncology Cardiff Oncology
CRDF
45.4 M $ 0.85 -4.67 % $ 56.8 M usaUSA
BioNTech SE BioNTech SE
BNTX
19.2 B $ 80.87 -0.63 % $ 19.5 B germanyGermany
Alkermes plc Alkermes plc
ALKS
1.82 B $ 44.89 -2.79 % $ 7.39 B irlandaIrlanda
ANI Pharmaceuticals ANI Pharmaceuticals
ANIP
541 M $ 68.6 -0.77 % $ 1.38 B usaUSA
AIM ImmunoTech AIM ImmunoTech
AIM
-9.78 M $ 0.11 -7.75 % $ 178 K usaUSA